Table 5.
Comparison of pre-treatment and final BCVA among four groups (Median, M(P25,P75), LogMAR)
| Items | A1 Group (n = 15) | A2 Group (n = 14) | t/Z | P₁* | B1 Group (n = 12) | B2 Group (n = 12) | /Z | Pz* |
|---|---|---|---|---|---|---|---|---|
| Pre-treatment visual acuity | 2.0(0.5,2.4) | 2.0(0.8,2.1) | -0.403 | 0.687 | 2.0(1.1,2.4) | 2.4(2.0,2.4) | -1.148 | 0.251 |
| Pre-treatment BCVA | 2.0(0.5,2.4) | 2.0(0.8,2.1) | -0.403 | 0.687 | 2.0(1.1,2.4) | 2.4(2.0,2.4) | -1.148 | 0.251 |
| Final BCVA | 0.7(0.3,1.6) | 1.1(0.8,1.7) | -0.810 | 0.425 | 1.0(0.7,1.4) | 1.0(0.7,1.9) | -0.131 | 0.897 |
*P¹, P₂: Statistical results comparing pre-treatment visual acuity, pre-treatment BCVA, and final BCVA between A1 vs. A2 groups and B1 vs. B2 groups, respectively